Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Probiotic spray is a microbial therapy formulation containing probiotics and lactic acid, currently under investigation for the treatment and prevention of oropharyngeal gonorrhoea. Developed by the Xi'an Jiaotong University Health Science Center, the spray is designed to restore the oropharyngeal microbiome and inhibit the colonization and growth of *Neisseria gonorrhoeae*. The inclusion of lactic acid helps maintain an acidic environment that is detrimental to the pathogen. It is being evaluated in a Phase 0 randomized controlled trial specifically targeting men who have sex with men (MSM).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on probiotic spray.